(Q47876362)

English

Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study

scientific article published in January 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

Elisabet Svenungsson

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

object named as

A Zandian

3

0 references

object named as

A Checa

1

0 references

2

object named as

H Idborg

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

author name string

D Garcia Sar

4

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

I Surowiec

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

J Trygg

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

P-J Jakobsson

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

I Gunnarsson

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

C E Wheelock

11

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

publication date

1 January 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

26

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

1023-1033

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

Principles of bioactive lipid signalling: lessons from sphingolipids

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Many ceramides.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Sphingolipid metabolites in inflammatory disease

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Accelerated vascular disease in systemic lupus erythematosus: role of macrophage

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Normalizing glycosphingolipids restores function in CD4+ T cells from lupus patients.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Metabolomics for rheumatic diseases: has the time come?

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Cluster analysis of autoantibodies in 852 patients with systemic lupus erythematosus from a single center

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney disease

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Ceramides and cardiac function in children with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Glycosphingolipids and kidney disease

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Association of ceramides in human plasma with risk factors of atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Quantification of sphingosine 1-phosphate by validated LC-MS/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1177%2F0961203316686707

21 January 2018

Identifiers

10.1177/0961203316686707

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/28134039

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47876362&oldid=2174224352"